Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects.

Roudi, Raheleh; D'Angelo, Alberto; Sirico, Marianna; Sobhani, Navid

Roudi, Raheleh; D'Angelo, Alberto; Sirico, Marianna; Sobhani, Navid.

Afiliação

Roudi R; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
D'Angelo A; Department of Biology & Biochemistry, University of Bath, Bath BA2-7AX, UK.
Sirico M; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy.
Sobhani N; Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: navid.sobhani@bcm.edu.

Int Immunopharmacol ; 101(Pt A): 108322, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34735916

Assuntos

Carcinoma Hepatocelular/terapia; Imunoterapia/métodos; Neoplasias Hepáticas/terapia; Animais; Antineoplásicos Imunológicos/uso terapêutico; Carcinoma Hepatocelular/imunologia; Humanos; Neoplasias Hepáticas/imunologia

Palavras-chave

Anti-CTLA-4; Anti-PD-1; DC/CIK therapy; Hepatocellular carcinoma; Immune checkpoint inhibitors; Immunotherapy; Liver cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Imunoterapia / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google